Kaleido Biosciences (KLDO) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock KLDO vs. ELYS, PRST, DMN, GROM, KBNT, ALFIW, APCXW, ARBEW, AOGOW, and AOGOUShould you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Elys BMG Group (ELYS), Presto Automation (PRST), Grafiti (DMN), Grom Social Enterprises (GROM), Kubient (KBNT), Alfi (ALFIW), AppTech Payments (APCXW), Arbe Robotics (ARBEW), Arogo Capital Acquisition (AOGOW), and Arogo Capital Acquisition (AOGOU). These companies are all part of the "computer software" industry. Kaleido Biosciences vs. Its Competitors Elys BMG Group Presto Automation Grafiti Grom Social Enterprises Kubient Alfi AppTech Payments Arbe Robotics Arogo Capital Acquisition Arogo Capital Acquisition Elys BMG Group (NASDAQ:ELYS) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap computer software companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends. Does the media favor ELYS or KLDO? In the previous week, Elys BMG Group had 1 more articles in the media than Kaleido Biosciences. MarketBeat recorded 1 mentions for Elys BMG Group and 0 mentions for Kaleido Biosciences. Elys BMG Group's average media sentiment score of 0.00 equaled Kaleido Biosciences'average media sentiment score. Company Overall Sentiment Elys BMG Group Neutral Kaleido Biosciences Neutral Is ELYS or KLDO more profitable? Company Net Margins Return on Equity Return on Assets Elys BMG GroupN/A N/A N/A Kaleido Biosciences N/A N/A N/A Which has preferable valuation & earnings, ELYS or KLDO? Elys BMG Group has higher revenue and earnings than Kaleido Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElys BMG Group$43.86M0.00-$18.26MN/AN/AKaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A Do insiders and institutionals believe in ELYS or KLDO? 81.6% of Kaleido Biosciences shares are owned by institutional investors. 18.5% of Elys BMG Group shares are owned by company insiders. Comparatively, 9.0% of Kaleido Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, ELYS or KLDO? Elys BMG Group has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Comparatively, Kaleido Biosciences has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. SummaryElys BMG Group beats Kaleido Biosciences on 5 of the 6 factors compared between the two stocks. Get Kaleido Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLDO vs. The Competition Export to ExcelMetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.39M$127.96M$5.55B$9.04BDividend YieldN/A3.74%5.22%3.99%P/E Ratio0.003.4027.6620.24Price / SalesN/A4,084.30418.72118.54Price / CashN/A13.1936.8958.10Price / BookN/A42.828.035.67Net Income-$95.48M-$92.79M$3.18B$249.21M Kaleido Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLDOKaleido BiosciencesN/AN/AN/AN/A$6.39M$1.10M0.0080ELYSElys BMG GroupN/A$0.00flatN/A-99.6%$16K$43.86M0.0090News CoveragePRSTPresto Automation0.1242 of 5 stars$0.00flatN/A-99.9%$10K$19.05M0.004DMNGrafitiN/A$0.00-77.3%N/AN/A$8K$386.09K0.00N/AGap DownHigh Trading VolumeGROMGrom Social EnterprisesN/A$0.00flatN/A-99.7%$8K$3.72M0.00450Gap DownKBNTKubientN/AN/AN/AN/A$1K$1.17M0.0040ALFIWAlfiN/AN/AN/AN/A$0.00$200.68K0.0040APCXWAppTech PaymentsN/A$0.06-77.6%N/AN/A$0.00$276K0.0020Gap UpARBEWArbe RoboticsN/A$0.22+7.4%N/A-0.6%$0.00$671K0.00120Gap DownAOGOWArogo Capital AcquisitionN/A$0.03flatN/AN/A$0.00N/A0.00N/AGap DownAOGOUArogo Capital AcquisitionN/A$8.50flatN/AN/A$0.00N/A0.00N/A Related Companies and Tools Related Companies Elys BMG Group Competitors Presto Automation Competitors Grafiti Competitors Grom Social Enterprises Competitors Kubient Competitors Alfi Competitors AppTech Payments Competitors Arbe Robotics Competitors Arogo Capital Acquisition Competitors Arogo Capital Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLDO) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KLDO Stock Alerts